Add Yahoo as a preferred source to see more of our stories on Google. Looking back, Kokomo resident Mike Beatty knew he had something as a teenager, but he couldn’t put a name to it. Whenever he’d ...
Dear Dr. Roach: I was diagnosed with atrial fibrillation in January 2012. I am aware of when it comes by how I feel — a little out of sorts, but no shortness of breath, chest pain or light-headedness.
Jacksonville Journal-Courier on MSN
A-fib increasing, but treatments improving
Atrial fibrillation, or A-fib, is a quivering or irregular heartbeat that can lead to blood clots, stroke and heart failure.
DEAR DR. ROACH: I was diagnosed with atrial fibrillation in January 2012. I am aware of when it comes by how I feel -- a little out of sorts, but no shortness of breath, chest pain or light-headedness ...
A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Previously, patients with advanced atrial fibrillation (AF ...
In a closely watched medical development, Medtronic edged out competitors in securing U.S. Food and Drug Administration approval for a new cardiac device designed to treat a specific type of irregular ...
Heart arrhythmias are usually harmless, but some can be life threatening. Treatments help correct your heart rate to prevent serious health issues. When the electrical impulses that affect your ...
All the selected patients for the study were under antiarrhythmic drug treatment (amiodarone 200 mg/day) before the procedure and during the whole follow-up after ECV. Moreover, all of them were also ...
It is expected that within the next 20 years that 20 million-60 million people will get atrial fibrillation, usually just called AFib. People with AFib have a five-times increased risk of stroke ...
Acesion Pharma has early clinical evidence that its new approach to treating atrial fibrillation works. In a phase 2 clinical trial, recipients of the biotech’s first-in-class ion channel inhibitor ...
Recurrent arrhythmia, where irregular heart rhythms return even after treatment, can present challenges and increase the risk of complications, but can be managed with a cardiologist’s help and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results